Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Samsung Biologics (207940) – (Correction) Contract Signings for Supply and Sales / 2026-06-09 Disclosures
  • [Disclosure] Celltrion (068270) – Provisional Sales Results (Consolidated Financial Statements) / 2024-05-09 Bio & Healthcare
  • [Disclosure] LEENO Industrial (058470) – (Correction) Cash/In-kind Dividend Decision / 2024-12-26 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – DS Investment | Contract Pricing · LTA · DRAM Supply Shortage / 2026-04-09 RESEARCH
  • [Disclosure] Hanwha Ocean (042660) – (Correction) Acquisition of Shares and Equity Securities of Other Corporations / 2025-12-23 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Holding / 2025-12-30 Semiconductors
  • [Disclosure] HPSP (403870) – (Correction) Change of Largest Shareholder / 2025-05-16 Semiconductors

[Disclosure] ISU PETASYS (007660) – Other Management Matters (Voluntary Disclosure) / 2024-12-20

Posted on December 20, 2024August 1, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

ISU PETASYS announced that its year-end dividend record date has been changed from December 31 to a date to be determined by the Board of Directors, advising that holding shares on December 31, 2024, alone will not guarantee dividend eligibility unless held on the upcoming record date.

📊 [Key Disclosure Details & Financial Summary]

  1. Disclosure Title: Notice on Change of Dividend Record Date following Improvement of Dividend Procedures
  2. Change in Dividend Record Date:
  • Previously: End of each fiscal year (December 31)
  • Amended: A date to be determined by the Board of Directors
  1. Investor Notice:
  • Holding ISU PETASYS shares on December 31, 2024 (end of the fiscal year) does not grant dividend eligibility unless the shares are held on the official year-end dividend record date to be determined and disclosed by the Board of Directors later.
  1. Other Notes:
  • Details including dividend eligibility, final record date, and dividend per share will be determined at upcoming Board of Directors and Annual General Shareholders’ meetings.
  • The underlying amendment to the Articles of Incorporation was approved at the 52nd Annual General Meeting of Shareholders on March 29, 2024.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Dividend Record Date and Dividend Terms to be Announced in Future Board Resolutions

The company modified its dividend record date structure to be set after the dividend amount is determined by the Board. Verifying the exact dividend record date and dividend per share in future disclosures is important to confirm eligibility for the 2024 year-end dividend payout. Relevant details can be tracked through upcoming disclosures on ‘Decision on Cash/In-kind Dividend’ and Annual General Meeting notices.

📢 Disclaimer & Source Notice

Source: This content has been newly structured and created based on official filing data from the Financial Supervisory Service DART system.

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific securities. All investment decisions and financial liabilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Semiconductors, Disclosures

Post navigation

Previous Post: [Disclosure] KEPCO (015760 / KEP) – Resolution on Convening of General Shareholders Meeting / 2024-12-20
Next Post: [Disclosure] SK Square (402340) – Major Management Matters Related to Investment Decisions / 2024-12-20

Related Posts

  • [Disclosure] Hanwha Aerospace (012450) – (Correction) Supply Contract / 2025-03-11 Disclosures
  • [Disclosure] KEPCO (015760 / KEP) – Domestic Filing of Annual Report Submitted to Foreign Stock Exchange / 2024-05-02 Disclosures
  • [Disclosure] Jeju Semiconductor (080220) – Change in Revenue or Loss/Profit Structure Exceeding 30% (15% for Large Companies) / 2024-02-28 Semiconductors
  • [Disclosure] Hanmi Semiconductor (042700) – Decision on Acquisition of Shares and Investment Certificates of Other Corporations / 2026-06-12 Semiconductors
  • [Disclosure] KEPCO (015760 / KEP) – Serious Industrial Accident / 2026-03-19 Disclosures
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Submission of Audit Report / 2024-03-18 Disclosures
  • [Disclosure] LEENO Industrial (058470) – Resolution on Convocation of Annual General Meeting of Shareholders / 2024-02-26 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Execution of Exclusive License Agreement (ALT-B4 Technology) / 2024-11-08 Disclosures
  • [Disclosure] Hanwha Systems (272210) – Sales and Supply Contract / 2024-12-18 Disclosures
  • [Disclosure] Celltrion (068270) – CT-P55 (Cosentyx Biosimilar) Korea Marketing Authorization Application / 2026-06-26 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Exercise and Non-Exercise of Voting Rights by Trustee / 2026-03-20 Disclosures
  • [Disclosure] Celltrion (068270) – Approval of Part 1 Clinical Trial Application for Phase 3 Trial of CT-P44 (Darzalex Biosimilar) in Europe / 2025-04-01 Disclosures
  • [Disclosure] Celltrion (068270) – Application for Amendment of Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in Korea (Correction) / 2026-04-24 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme